Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Nov;37(11):e141-e143.
doi: 10.1097/IAE.0000000000001887.

Reply

Qi Sheng You  1 , Amit Meshi, Ilkay K Muftuoglu, William R Freeman
Affiliations
Comment

Reply

Qi Sheng You et al. Retina. 2017 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Proprietary interest: no proprietary interest exists for any author.

Comment on

References

    1. Călugăru D, Călugăru M. Letter to the editor. High dose high frequency aflibercept for recalcitrant neovascular age-related macular degeneration
    1. You QS, Gaber R, Meshi A, et al. High-dose high-frequency aflibercept for recalcitrant neovascular age-related macular degeneration. Retina. 2017 Epub ahead of print. - PMC - PubMed
    1. Mojana F, Cheng L, Bartsch DU, et al. The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results. Am J Ophthalmol. 2008;146:218–227. - PMC - PubMed
    1. Chhablani J, Kozak IR, Mojana F, et al. Fundus autofluorescence not predictive of treatment response to intravitreal bevacizumab in exudative age-related macular degeneration. Retina. 2012 Sep;32:1465–70. - PubMed
    1. Chhablani J, Kim JS, Freeman WR, et al. Predictors of visual outcome in eyes with choroidal neovascularization secondary to age related macular degeneration treated with intravitreal bevacizumab monotherapy. Int J Ophthalmol. 2013;6:62–6. - PMC - PubMed